.jpg?#)
Glenmark Arm IGI's AbbVie Deal Unfolds Blockbuster Potential, Says Motilal Oswal - Read Report
Based on the contours of the deal, Motilal Oswal adds an NPV of Rs 470 per share to the 27x 12M forward base business earnings to arrive at a target price of Rs 2,430.
Based on the contours of the deal, Motilal Oswal adds an NPV of Rs 470 per share to the 27x 12M forward base business earnings to arrive at a target price of Rs 2,430.
What's Your Reaction?
